Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bella, and I will be your conference operator today.
Seres Therapeutics Inc. (MCRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,810,719 | $1,504,707 | +78% | 0% |
| 2. | Lion Point Didric Cederholm | 340,761 | $283,172 | 1.48% | |
| 3. | 248,600 | $206,587 | +31% | 0% | |
| 4. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 100,700 | $83,681 | -77% | 0% |
| 5. | Engineers Gate Manager Greg Eisner | 84,986 | $70,623 | -19% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | Large Shareholder | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | Large Shareholder | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.54 | 878 | 135,192 | 2024-11-18 | Filing | ||
| $0.54 | 977 | 32,415 | 2024-11-18 | Filing | ||
| $0.54 | 735 | 90,404 | 2024-11-18 | Filing | ||
| $0.54 | 2,505 | 170,389 | 2024-11-18 | Filing | ||
| $0.54 | 927 | 77,770 | 2024-11-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,117,045 | $19,251,994 | 5.76% | |
| 2. | 21,811,697 | $18,125,520 | 0% | |
| 3. | 5,873,880 | $4,881,194 | 0% | |
| 4. | 2,673,800 | $2,219,254 | 0% | |
| 5. | 2,013,251 | $1,673,011 | 0% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2022 Earnings Call Transcript
Operator: Thank you for holding, and welcome everyone, to the Seres Therapeutics Fourth Quarter 2022 Conference Call. . Thank you. I will now turn the call over to Dr.
Cathie Wood's Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.